Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding eligibility criteria, prior authorization and costs.
Some Medicare patients can now receive GLP-1 medication at a low cost.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果